...
首页> 外文期刊>Clinical and investigative medicine: Medecine clinique et experimentale >Association of serum fetuin-A levels with heart valve calcication and other biomarkers of inflammation among persons with acute coronary syndrome
【24h】

Association of serum fetuin-A levels with heart valve calcication and other biomarkers of inflammation among persons with acute coronary syndrome

机译:急性冠状动脉综合征患者血清胎球蛋白A水平与心脏瓣膜钙化和其他炎症生物标志物的关系

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: Fetuin-A is a multifunctional hepatic secretory protein that inhibits dystrophic vascular and valvular calcification. Our aim was to evaluate the relationship among fetuin-A levels, heart valve calcification and other biomarkers of inflammation in patients with acute coronary syndrome (ACS). Methods: The associations among serum fetuin-A concentrations, mitral annular (MAC) and aortic valve calcification and other biomarkers of inflammation (hs-CRP, ferritin, fibrinogen, white blood cell count (WBC), erythrocyte sedimentation rate (ESR), albumin levels) were evaluated in ACS patients and healthy controls. The study included 95 patients (mean age 61.8±12.10 years) and 81 healthy controls (mean age 48.33±9.19 years). Results: Fetuin-A levels were significantly lower in patients with ACS than in healthy controls (0.76 ± 0.23 and 1.10 ± 0.45 g/L, respectively, p<0.001). Fetuin-A was lower in patients with mitral annular calcification (p=0.007) and aortic (p=0.001) valve calcification. In patients with ACS, there was a negative correlation among serum urea (r=-0.377, p<0.001) and creatinine (r=-0.232, p=0.024) levels and fetuin-A, and a negative correlation among WBC (r=-0.156, p=0,132), ESR (r=-0.214, p=0.037), hs-CRP (r=-0.220, p=0.032) levels and fetuin-A. A positive correlation was seen between albumin and fetuin-A (r=0.362, p<0.001). Multivariate logistic regression analysis revealed that fetuin-A was the variable that had a significant effect on ACS (p = 0.020 OR = .015, (95% CI)(0.000-0.520). Conclusion, Fetuin-A levels decrease in patients with acute coronary syndromes, independent of heart valve calcification: Fetuin-A may therefore act as a negative acute phase protein after myocardial infarction.
机译:目的:Fetuin-A是一种多功能的肝分泌蛋白,可抑制营养不良的血管和瓣膜钙化。我们的目的是评估急性冠状动脉综合征(ACS)患者的胎球蛋白A水平,心脏瓣膜钙化和其他炎症生物标志物之间的关系。方法:血清胎球蛋白A浓度,二尖瓣环(MAC)和主动脉瓣钙化以及其他炎症生物标志物(hs-CRP,铁蛋白,纤维蛋白原,白细胞计数(WBC),红细胞沉降率(ESR),白蛋白之间的关系水平)在ACS患者和健康对照中进行了评估。该研究包括95位患者(平均年龄61.8±12.10岁)和81位​​健康对照(平均年龄48.33±9.19岁)。结果:ACS患者的胎球蛋白A水平显着低于健康对照组(分别为0.76±0.23和1.10±0.45 g / L,p <0.001)。二尖瓣环钙化(p = 0.007)和主动脉瓣膜钙化(p = 0.001)患者的胎球蛋白-A水平较低。在ACS患者中,血清尿素(r = -0.377,p <0.001)和肌酐(r = -0.232,p = 0.024)水平与胎球蛋白A之间呈负相关,而WBC之间呈负相关(r = -0.156,p = 0,132),ESR(r = -0.214,p = 0.037),hs-CRP(r = -0.220,p = 0.032)水平和胎球蛋白A.在白蛋白和胎球蛋白-A之间发现正相关(r = 0.362,p <0.001)。多因素logistic回归分析表明,胎球蛋白A是对ACS有显着影响的变量(p = 0.020 OR = .015,(95%CI)(0.000-0.520)。独立于心脏瓣膜钙化的冠状动脉综合征:因此,Fetuin-A可能在心肌梗塞后充当阴性急性期蛋白。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号